Breast Cancer
Expert treatment for breast cancer including surgery, chemotherapy, targeted therapy, hormone therapy, and radiation therapy with personalized care.
Breast Cancer
Solid Tumors
Overview
Expert treatment for breast cancer including surgery, chemotherapy, targeted therapy, hormone therapy, and radiation therapy with personalized care.
When to Consult
Upon detection of breast lump, abnormal mammogram, or confirmed breast cancer diagnosis.
What to Bring
Mammogram reports, breast biopsy results, ultrasound reports, hormone receptor test results, and genetic testing if available.
Risk Factors
Causes
Treatment Options
Surgery
Surgical options include lumpectomy (breast-conserving surgery), mastectomy (removal of entire breast), or nipple-sparing mastectomy. Sentinel lymph node biopsy or axillary lymph node dissection may be performed to check for cancer spread.
Chemotherapy
Systemic drug therapy administered before surgery (neoadjuvant) to shrink tumors, or after surgery (adjuvant) to eliminate remaining cancer cells. Common regimens include anthracyclines, taxanes, and platinum-based drugs tailored to cancer subtype.
Hormone Therapy
For hormone receptor-positive breast cancer, treatments include tamoxifen, aromatase inhibitors (letrozole, anastrozole, exemestane), or ovarian suppression. Blocks estrogen/progesterone effects on cancer cells, reducing recurrence risk.
Targeted Therapy
Precision treatments including HER2-targeted therapies (trastuzumab, pertuzumab, T-DM1) for HER2-positive cancers, CDK4/6 inhibitors (palbociclib, ribociclib) for hormone-positive cancers, and PARP inhibitors for BRCA-mutated cancers.
Radiation Therapy
High-energy radiation to destroy remaining cancer cells after surgery, reduce local recurrence risk, or treat metastatic sites. Techniques include whole-breast radiation, partial-breast irradiation, or accelerated protocols.
Immunotherapy
Immune checkpoint inhibitors (pembrolizumab) combined with chemotherapy for triple-negative breast cancer. Helps the immune system recognize and attack cancer cells, particularly effective in PD-L1 positive tumors.